Drawing for HEAL TECHNOLOGY

USPTO serial 97871705

HEAL TECHNOLOGY

Reviewed by CopyMark Law Group

Reg. 7575527Status 700Registered
Filing date
Status date
Registration date
Nov 26, 2024
Examiner
ANDERSON, DANIELLE LYNN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HEAL TECHNOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kathryn A. Gromlovits

Kathryn A. Gromlovits SHUMAKER, LOOP & KENDRICK, LLP101 SOUTH TRYON STREETSUITE 2200CHARLOTTE, NC 28280

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of strokes and neurovascular disorders; Pharmaceutical preparations and natural dietary supplements for treatment and alleviation of symptoms and causes of neurological disorders, in particular neurological disorders affecting the central nervous system, the peripheral nervous system and the autonomic nervous system; Pharmaceutical preparations and natural dietary supplements for treatment and alleviation of symptoms and causes of brain injury, in particular stroke, brain trauma and global ischemia; Pharmaceutical preparations and natural dietary supplements for treatment and alleviation of symptoms and causes of neurodegenerative disorders; Pharmaceutical preparations and natural dietary supplements for treatment and alleviation of symptoms and causes of stroke and dementia in particular, Alzheimer's disease, Parkinson's disease, senile dementia and Huntington's disease; Pharmaceutical preparations and additives in the nature of dietary supplements for neuroprotection in particular for treatment and alleviation of symptoms of strokes; Medical instruments and apparatus, namely, delivery apparatus for fibrin sealant and fibrin scaffold; Bio-functional antithrombogenic and endothelialisation coatings, namely, drug delivery agents in the form of a coating for stents that facilitate the delivery of a wide range of pharmaceuticals for treatment of neurovascular diseases; Biological skin tissue intended for subsequent implantation; Tissues for surgical use being surgical implants comprised of living tissues; Pharmaceutical preparations in liquid form for the treatment of neurological and neurovascular disorders; pharmaceutical preparations, namely, liquid embolic agentsACTIVE—
010Surgical and medical apparatus for use in treating stroke and blockage or inflammation of cerebral vessels; surgical devices and instruments; Medical stents in the nature of surgical implant made of synthetic materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies; Grafts being surgical implants made of artificial materials; Flow diverters, namely, surgical implants comprised of artificial materials; Medical guidewires and medical filters being blood filters, for use in the fields of Radiology, Cardiology and Neurology for the treatment of strokes and neurovascular disorders; Surgical and medical instruments, namely, stent-retrievers and stents for blood and blood components for medical purposes for use in the radiology, cardiology and neurology sectors, in particular for treating strokes and neurovascular disorders; Medical recanalisation devices for use in treating blood clots; Medical embolisation devices for use in treating hemoptysis; Medical application systems for surgical and medical apparatus, devices and instruments, in particular catheters; Medical devices, namely, pulse generators used with a neurostimulation system for neurostimulation; Prosthetic tissues for vascular use; Medical electrodes for the simulation of nerve paths; Medical electrodes for the treatment of epilepsy and Alzheimer's diseaseACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 26, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 26, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 24, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 24, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 4, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 19, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 14, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 14, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 14, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 30, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 30, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 30, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 27, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 27, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 27, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 8, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Apr 8, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jan 8, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 8, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 8, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 30, 2023DOCKASSIGNED TO EXAMINER—
Apr 28, 2023MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Apr 27, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 7, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance